USANA Health Sciences (NYSE:USNA) Issues Earnings Results

USANA Health Sciences (NYSE:USNA - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.20, Zacks reports. USANA Health Sciences had a net margin of 3.79% and a return on equity of 9.48%. The business had revenue of $235.85 million during the quarter, compared to analysts' expectations of $225.20 million. USANA Health Sciences updated its FY 2025 guidance to 2.350-3.000 EPS.

USANA Health Sciences Stock Down 0.4%

Shares of USNA stock traded down $0.13 on Friday, reaching $31.97. The company had a trading volume of 175,530 shares, compared to its average volume of 137,350. The stock has a market capitalization of $595.19 million, a PE ratio of 17.76, a price-to-earnings-growth ratio of 1.02 and a beta of 0.64. USANA Health Sciences has a one year low of $23.10 and a one year high of $45.86. The business's 50-day moving average is $30.86 and its 200 day moving average is $30.11.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of USANA Health Sciences from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.

Insider Transactions at USANA Health Sciences

In other news, COO Walter Noot sold 6,291 shares of the company's stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total value of $190,554.39. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO G Doug Iiekking sold 4,548 shares of the company's stock in a transaction that occurred on Friday, May 9th. The shares were sold at an average price of $29.61, for a total value of $134,666.28. The disclosure for this sale can be found here. Insiders sold 12,013 shares of company stock valued at $360,149 in the last three months. Company insiders own 0.63% of the company's stock.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in USANA Health Sciences stock. Empowered Funds LLC acquired a new stake in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 25,483 shares of the company's stock, valued at approximately $687,000. Empowered Funds LLC owned 0.14% of USANA Health Sciences at the end of the most recent reporting period. Institutional investors own 54.25% of the company's stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.